Immediate Impact
54 standout
Citing Papers
Applications of liposomes and lipid nanoparticles in cancer therapy: current advances and prospects
2025 Standout
Development of NK cell-based cancer immunotherapies through receptor engineering
2024 Standout
Works of Bernd Kost being referenced
TA-MUC1 as detected by the fully humanized, therapeutic antibody Gatipotzumab predicts poor prognosis in cervical cancer
2018
The G protein-coupled estrogen receptor (GPER/GPR30) may serve as a prognostic marker in early-stage cervical cancer
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Bernd Kost | 102 | 46 | 130 | 81 | 30 | 411 | |
| A. Bichler | 76 | 45 | 82 | 37 | 24 | 401 | |
| Jacqueline L. Olin | 58 | 38 | 114 | 85 | 35 | 447 | |
| Annie J. Kruger | 175 | 18 | 87 | 75 | 19 | 407 | |
| Jianhui Fan | 79 | 44 | 99 | 34 | 23 | 425 | |
| Nirmala D. Sirisena | 56 | 35 | 144 | 23 | 51 | 449 | |
| Miriam Marquis | 70 | 51 | 166 | 108 | 19 | 435 | |
| Arnaud Ferraris | 31 | 14 | 85 | 55 | 25 | 341 | |
| Katharina Herzog | 67 | 45 | 211 | 14 | 18 | 399 | |
| Dajiang Li | 85 | 56 | 130 | 89 | 23 | 352 | |
| Knut Anders Mosevoll | 81 | 41 | 115 | 82 | 24 | 430 |
All Works
Login with ORCID to disown or claim papers
Loading papers...